MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Distinct amyloid-dependent patterns of nigral dopamine depletion in Lewy body diseases

    K. Baik, J. Cha, M. Park, Y. Lee, SW. Kang, SH. Yoon, H. Na, Y. Sohn, P. Lee (Seoul, Republic of Korea)

    Objective: To investigate the effect of amyloid on striatal 18F-FP-CIT uptake patterns in Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy…
  • 2022 International Congress

    Neural and cognitive correlates of the co-occurrence of apathy and Impulse Control Disorder in early Parkinson’s Disease

    G. Maggi, S. Costa, F. Loayza, G. Santangelo, I. Obeso (Caserta, Italy)

    Objective: The present study aims to explore the co-occurrence of impulse control disorder (ICD) and apathy and its neural correlates analyzing anatomical changes in gray…
  • 2022 International Congress

    Anatomical Substrates for Motor Subcomponents of Bradykinesia in Parkinson’s Disease after Subthalamic Nucleus Deep Brain Simulation

    MJ. Kim, Y. Shi, Y. Salimpour, WS. Anderson, K. Mills (Baltimore, USA)

    Objective: To evaluate distinct anatomical substrates modulating motor subcomponents of bradykinesia following Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD). Background: PD…
  • 2022 International Congress

    WATCH-PD: Baseline Phenotype and Longitudinal Digital Assessments in Early PD

    T. Kangarloo, E. Dorsey, P. Auinger, D. Volfson, J. Padmanabhan, B. Tracey, RS. Latzman, P. Artoni, Y. Gong, A. Best, J. Severson, D. Anderson, M. Kostrzebski, A. Stevenson, P. Wilmot, Y. Pohlson, J. Cosman, K. Praneeth Kilambi, J. Edgerton, J. Adams (Cambridge, USA)

    Objective: To provide a longitudinal profile of early Parkinson’s (PD) disease progression using clinical and digital measures, and to evaluate the extent to which digital…
  • 2022 International Congress

    Treatment Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease: The Search for the Ideal Neuroprotective Drug

    C. Gonzalez-Robles, D. Byrom, R. Chapman, D. Dexter, S. Duty, R. Ellis-Doyle, E. Jabbari, G. Mills, H. Mortiboys, J. Rudiger, E. Sammler, P. Scurfield, S. Stott, G. Tofaris, L. Wei, A. Wong, ML. Zeissler, C. Carroll, T. Foltynie, O. Bandmann, A. Schapira (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatments for…
  • 2022 International Congress

    Head injury prior to Parkinson’s disease predicts faster self-reported motor and cognitive decline

    E. Brown, M. San Luciano, S. Goldman, M. Korell, B. Contreras, C. Tanner (San Francisco, USA)

    Objective: To compare rates of self-reported cognitive and motor decline in people with Parkinson’s Disease (PD) with and without a history of head injury (HI).…
  • 2022 International Congress

    Patient Advisory Boards: A Model for Patient Engagement in Parkinson’s Disease Comparative Effectiveness Research

    K. Schroeder, C. Gallagher, M. Armstrong, M. Carnie, C. Evers, J. Fleisher, B. Kluger, J. Lamb, S. Seshadri, L. Wilson, M. Feeney, P. Davies (New York, USA)

    Objective: To build a replicable, sustainable model of patient engagement in Parkinson’s disease (PD) comparative effectiveness research (CER) at academic research centers through patient advisory…
  • 2022 International Congress

    Caregiver burden in Parkinson’s Disease patients with Cardiovascular Dysautonomia

    C. Ledda, G. Imbalzano, C. Artusi, A. Merola, E. Montanaro, M. Zibetti, M. Rizzone, G. Sobrero, F. Vallelonga, S. Maule, L. Lopiano, A. Romagnolo (Turin, Italy)

    Objective: We sought to estimate the impact of cardiovascular autonomic neuropathy (cAN) on informal caregivers of patients with Parkinson’s disease (PD), defined as individuals providing regular…
  • 2022 International Congress

    An accurate yet practical method for DBS battery life prediction

    S. Jinks (Sacramento, USA)

    Objective: To develop a simple, accurate algorithm for predicting DBS IPG battery life in patients with PD, ET and dystonia. Background: Battery life for DBS…
  • 2022 International Congress

    Correlation between cognitive impairment and neuropsychiatric symptoms in Mexican persons living with Parkinson’s disease.

    GI. Cerda-Hernández, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)

    Objective: To describe the association amongst depression, anxiety, psychosis with cognitive impairment in Mexican people living with Parkinson’s disease (PwP). Background: Cognitive impairment and neuropsychiatric…
  • « Previous Page
  • 1
  • …
  • 459
  • 460
  • 461
  • 462
  • 463
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley